Literature DB >> 22886984

Incidence of childhood cancer among Mexican children registered under a public medical insurance program.

Roberto Rivera-Luna1, Cecilia Correa-González, Eduardo Altamirano-Alvarez, Fernando Sánchez-Zubieta, Rocio Cárdenas-Cardós, Gabriela Escamilla-Asian, Alberto Olaya-Vargas, Aurora Bautista-Marquez, Manuel Aguilar-Romo.   

Abstract

Prior to 2005, 51% of children in Mexico diagnosed with cancer received no standardized optimal multidisciplinary medical care. A government-subsidized national cancer treatment program was therefore created for these patients and a National Cooperative Childhood Cancer Treatment Group was consequently formed for these patients. Pediatric patients with a proven diagnosis of leukemia, lymphoma or solid tumor and who were registered in the Popular Medical Insurance (PMI) program from January 2007 to December 2010, are described in this report. These patients had been enrolled and registered in one of the 49 nationwide certified medical institutions in Mexico. The national incidence and frequency data for childhood cancers were analyzed for the whole program. At the end of a 4-year study, the analysis revealed that 8,936 children from across Mexico had been diagnosed with cancer. The incidence rate for the PMI patients was 150.3/million/year (2010) for children of 0-18 years. The highest age incidence rate was 51.9 between 0 and 4 years and boys were the predominant group for all types of cancer. The leukemia incidence was 75.3/million/year (2010), and an average frequency of 50.75% throughout the 4 years. The overall mortality rate was measured at 5.4/100,000/year (2010). This study demonstrates a high frequency and incidence of childhood cancer and a beneficial impact of the PMI program over the quality of life in these children.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22886984     DOI: 10.1002/ijc.27771

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Authors:  Cindy E Jiménez-Ávila; Vanessa Villegas-Ruíz; Marta Zapata-Tarres; Alejandra E Rubio-Portillo; Eleazar I Pérez López; Juan C Zenteno; Sergio Juárez-Méndez
Journal:  Int J Mol Epidemiol Genet       Date:  2018-10-20

2.  Addressing regional disparities in pediatric oncology: Results of a collaborative initiative across the Mexican-North American border.

Authors:  Paula Aristizabal; Spencer Fuller; Rebeca Rivera-Gomez; Mario Ornelas; Laura Nuno; Carlos Rodriguez-Galindo; Raul Ribeiro; William Roberts
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

3.  High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma.

Authors:  Lourdes Alvarez-Arellano; Pilar Eguía-Aguilar; Patricia Piña-Sánchez; Nadia González-García; Alam Palma-Guzman; Mario Perezpeña-Diazconti; Carmen Maldonado-Bernal
Journal:  Childs Nerv Syst       Date:  2021-09-04       Impact factor: 1.475

4.  Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia.

Authors:  Adriana Reyes-León; Rocío Juárez-Velázquez; Alma Medrano-Hernández; Teresa Cuenca-Roldán; Consuelo Salas-Labadía; María Del Pilar Navarrete-Meneses; Roberto Rivera-Luna; Gerardo López-Hernández; Rogelio Paredes-Aguilera; Patricia Pérez-Vera
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

5.  Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program.

Authors:  Roberto Rivera-Luna; Jaime Shalkow-Klincovstein; Liliana Velasco-Hidalgo; Rocio Cárdenas-Cardós; Marta Zapata-Tarrés; Alberto Olaya-Vargas; Marco R Aguilar-Ortiz; Eduardo Altamirano-Alvarez; Cecilia Correa-Gonzalez; Fernando Sánchez-Zubieta; Francisco Pantoja-Guillen
Journal:  BMC Cancer       Date:  2014-10-29       Impact factor: 4.430

6.  Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey.

Authors:  Paola Friedrich; Catherine G Lam; Geetinder Kaur; Elena Itriago; Raul C Ribeiro; Ramandeep S Arora
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

7.  Improving Pediatric Cancer Care Disparities Across the United States-Mexico Border: Lessons Learned from a Transcultural Partnership between San Diego and Tijuana.

Authors:  Paula Aristizabal; Spencer Fuller; Rebeca Rivera; David Beyda; Raul C Ribeiro; William Roberts
Journal:  Front Public Health       Date:  2015-06-22

8.  A New Method to Quantify Ifosfamide Blood Levels Using Dried Blood Spots and UPLC-MS/MS in Paediatric Patients with Embryonic Solid Tumours.

Authors:  Luz-María Torres; Liliana Rivera-Espinosa; Juan L Chávez-Pacheco; Carlos F Navas; Joel A Demetrio; Radamés Alemón-Medina; Francisca Trujillo; Martín Pérez; Martha M Zapata; Rocío Cárdenas; Citlaltepetl Salinas; Arnoldo Aquino; Rafael Velázquez-Cruz; Manuel-de-Jesús Castillejos
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

9.  Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries.

Authors:  Sumit Gupta; Roberto Rivera-Luna; Raul C Ribeiro; Scott C Howard
Journal:  PLoS Med       Date:  2014-06-17       Impact factor: 11.069

10.  Incidence and Trend of Childhood and Adolescent Cancers in Yazd, Iran.

Authors:  F Binesh; A Hashemi; M VakilI; M M Shakeri; R Masoumi Dehshiri
Journal:  Iran J Ped Hematol Oncol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.